• News
  • SAN DIEGO
  • Medical

Amgen, Illumina team on personalized medicine test

Biotech drugmaker Amgen and Illumina, a maker of genetic testing equipment, said Wednesday they are developing a test that will identify patients who might be helped by Amgen's colon cancer drug Vectibix.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
189.12
  3.28  
+ 1.76%
1,237,499,000
190.86
91.01

Insider Trade Data

Date Insider Shares Type Value
10/15/2014 Naclerio, Nicholas J 2,000 Sell $295,709
10/15/2014 Naclerio, Nicholas J 2,000 Exchange $86,740
10/14/2014 Stapley, Marc A 1,422 Sell $215,403
10/14/2014 Stapley, Marc A 1,422 Exchange $51,619
10/13/2014 Bradbury, Daniel M 2,100 Sell $319,257

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
SIC - 3826 - LABORATORY ANALYTICAL INSTRUMENTS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!